Evidence map›Paper›PMID 31772293›Full record

ArticleScientific reports2019

Spa-RQ: an Image Analysis Tool to Visualise and Quantify Spatial Phenotypes Applied to Non-Small Cell Lung Cancer.

Jie Bao, Margarita Walliander, Ferenc Kovács, Ashwini S Nagaraj, Annabrita Hemmes, Virinder Kaur Sarhadi, Sakari Knuutila, Johan Lundin, Peter Horvath, Emmy W Verschuren

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 3 countries.

Jie BaoInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, 00014, Finland.ORCID http://orcid.org/0000-0002-1993-7309
Margarita WallianderInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, 00014, Finland.
Ferenc KovácsSingle-Cell Technologies Ltd, Szeged, Hungary.
Ashwini S NagarajInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, 00014, Finland.
Annabrita HemmesInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, 00014, Finland.
Virinder Kaur SarhadiDepartment of Pathology, Haartman Institute, University of Helsinki, Helsinki, Finland.
Sakari KnuutilaDepartment of Pathology, Haartman Institute, University of Helsinki, Helsinki, Finland.
Johan LundinInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, 00014, Finland.
Peter HorvathInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, 00014, Finland.
Emmy W VerschurenInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, 00014, Finland. emmy.verschuren@helsinki.fi.ORCID http://orcid.org/0000-0001-5771-9129
University of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To facilitate analysis of spatial tissue phenotypes, we created an open-source tool package named 'Spa-RQ' for 'Spatial tissue analysis: image Registration & Quantification'. Spa-RQ contains software for image registration (Spa-R) and quantitative analysis of DAB staining overlap (Spa-Q). It provides an easy-to-implement workflow for serial sectioning and staining as an alternative to multiplexed techniques. To demonstrate Spa-RQ's applicability, we analysed the spatial aspects of oncogenic KRAS-related signalling activities in non-small cell lung cancer (NSCLC). Using Spa-R in conjunction with ImageJ/Fiji, we first performed annotation-guided tumour-by-tumour phenotyping using multiple signalling markers. This analysis showed histopathology-selective activation of PI3K/AKT and MAPK signalling in Kras mutant murine tumours, as well as high p38MAPK stress signalling in p53 null murine NSCLC. Subsequently, Spa-RQ was applied to measure the co-activation of MAPK, AKT, and their mutual effector mTOR pathway in individual tumours. Both murine and clinical NSCLC samples could be stratified into 'MAPK/mTOR', 'AKT/mTOR', and 'Null' signature subclasses, suggesting mutually exclusive MAPK and AKT signalling activities. Spa-RQ thus provides a robust and easy to use tool that can be employed to identify spatially-distributed tissue phenotypes.

Indexed as

Software3,3'-DiaminobenzidineBiomarkers, TumorCarcinoma, Non-Small-Cell LungGenes, rasHematoxylinHumansImage Processing, Computer-AssistedImmunoenzyme TechniquesLung NeoplasmsMAP Kinase Signaling SystemMitogen-Activated Protein Kinase KinasesNeoplasm ProteinsPhenotypePhosphoproteinsProof of Concept Study3,3'-DiaminobenzidineAkt1 protein, mouseBiomarkers, TumorHematoxylinMitogen-Activated Protein Kinase KinasesmTOR protein, mouseNeoplasm ProteinsPhosphoproteinsProto-Oncogene Proteins c-aktTOR Serine-Threonine Kinases

Identifiers

PMID31772293
PMCPMC6879493
OpenAlexW2989790155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.